...
首页> 外文期刊>Current medicinal chemistry >Novel biomarkers assessing the calcium deposition in coronary artery disease
【24h】

Novel biomarkers assessing the calcium deposition in coronary artery disease

机译:新型生物标记物评估冠状动脉疾病中的钙沉积

获取原文
获取原文并翻译 | 示例

摘要

Coronary atherosclerosis is the pathophysiologic background of coronary artery disease. Vascular calcification is an actively regulated form of calcified tissue metabolism and a common feature of coronary atherosclerotic plaques. Interestingly, systematic research has revealed that vascular mineralization, is also a strong and independent predictor of cardiovascular morbidity and mortality. Recently, several biomarkers, including osteopontin, fetuin-A, matrix-carboxyglutamic acid protein, pyrophosphates, bone morphogenetic proteins, leptin, osteoprotegerin have emerged as surrogate markers of coronary calcification. Furthermore, biomarkers of vascular calcification can be used as prognostic markers of coronary artery disease and can predict future cardiovascular events and mortality. Nevertheless, there is little knowledge on the usefulness of these biomarkers in evaluating the results of treatments targeting coronary artery disease. Within this context, the present review sets out to discuss the role of new biomarkers assessing calcium deposition in coronary arteries and their role in the prognosis, progression, and treatment of cardiovascular disease.
机译:冠状动脉粥样硬化是冠状动脉疾病的病理生理背景。血管钙化是钙化组织代谢的一种主动调节形式,是冠状动脉粥样硬化斑块的共同特征。有趣的是,系统研究表明,血管矿化也是心血管发病率和死亡率的强而独立的预测指标。近来,包括骨桥蛋白,胎球蛋白-A,基质-羧基谷氨酸蛋白,焦磷酸盐,骨形态发生蛋白,瘦素,骨保护素在内的几种生物标志物已成为冠状动脉钙化的替代标志物。此外,血管钙化的生物标志物可用作冠状动脉疾病的预后标志物,并可预测未来的心血管事件和死亡率。然而,关于这些生物标记物在评估针对冠状动脉疾病的治疗结果中的有用性的知识很少。在此背景下,本综述着手讨论评估钙在冠状动脉中沉积的新生物标记物的作用及其在心血管疾病的预后,进展和治疗中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号